Skip to content
GLP-1 Savers

Research & guides

How to Choose a GLP-1 Provider Without Overpaying

A savings-first checklist for picking a GLP-1 program: read the real 12-month price, verify the pharmacy, match the molecule, and skip teaser bait.

By Grant Ashford, Founder & Pricing Editor
What's in this guide

Choosing a GLP-1 program means checking medical suitability with a prescriber and comparing the complete price and service terms. The drugs work — semaglutide drove roughly 15% average body-weight loss over 68 weeks in the STEP-1 trial1, and tirzepatide reached up to about 21% in SURMOUNT-12. What differs wildly between telehealth providers is what you pay for the same molecule, and how honestly that price is presented. Here is how I would compare offers without treating different formulations as interchangeable.

Read the twelfth-month price, not the first

The single biggest overpay mistake is anchoring on the intro sticker. A $99 "first month" that quietly resets to $299 is not a $99 program — it is a $299 program with a discount coupon stapled to month one. Before you compare anything, find the price you will actually pay in month three, six, and twelve. Programs that publish one flat, all-in rate — the month-one rate is the month-twelve rate — are the ones you can trust to hold. That is exactly why our Value Score methodology weights "No Teaser-Rate Bait" as its own factor rather than folding it into price. The same trap has a quieter shape worth knowing: a program whose every advertised figure is the twelve-month prepay rung, so the price you would actually pay month to month is printed nowhere on its site. What an annual-prepay headline hides walks through one desk where the gap between the two is about 45%. And check the direction of the ladder before you assume committing is cheaper at all: on a desk whose tirzepatide bundles cost more the longer you sign up for, the month-to-month rate is the cheapest rate on offer, which is the opposite of what its "Best Value" badge tells you.

I would save the actual offer and cancellation terms before enrolling. Our CoreAge Rx review shows why a low product price still needs a checkout-total and refund check. The Shed review explains a different problem: lower advertised rates can require longer commitments, and the plan label may not establish the billing cycle.

Our Lean Meds review separates the headline rate from the plan term behind it. Its unresolved question is when the longer-plan payment is collected; request the amount due today and the renewal schedule before choosing a term.

Build a value checklist, not a price checklist

Price is one input, not the whole decision. The six things worth scoring before you commit:

  • Lowest real (ongoing) price, not the intro rate.
  • No teaser step-up — a flat price you can plan around.
  • Availability in your state, so the deal is actually reachable. Our Mint Med review explains why I would check the actual published state list and confirm eligibility rather than assume nationwide service.
  • Both molecules on offer, so you can switch without switching providers.
  • Easy cancellation with no lock-in or coaching bundle you can't leave.
  • Reputation and pharmacy verification.

A slightly higher flat price that scores well across all six usually beats a rock-bottom teaser that fails three of them.

Match the molecule to the price

Your prescriber should help choose the medicine and formulation that fit your medical needs. A lower advertised price does not establish equivalent treatment or the dose you will need. We break down the trade-off in semaglutide vs tirzepatide: the cheaper effective GLP-1, or shop the semaglutide-only price ranking and tirzepatide's price ranking directly. Picking the right molecule first often saves more than shaving a few dollars off the wrong one. For a smaller goal or a tighter budget, it's also worth knowing a GLP-1 isn't the only evidence-backed option — see phentermine vs GLP-1: cost and effectiveness compared for that specific trade-off.

Once you've picked the molecule, check that the program actually sells it by the month. That is not automatic: at one seller, tirzepatide has no monthly rung at all and the cheapest way in is $790 paid up front for twelve weeks, while its semaglutide plan is a real recurring rate. The opposite case is worth seeing too — a published one-, three- and six-month table with the monthly column labeled as such is the shape you want, and it is rarer than it ought to be.

For a concrete route comparison, the Henry Meds review separates its sublingual semaglutide offer from its injectable program. The OrderlyMeds review separates new-patient starter totals from ongoing prices. If no public quote can be verified, the Remedy Meds review explains what to request before handing over payment details. Those are three different pricing questions; one generic starting figure cannot answer them.

Verify the pharmacy before you celebrate the price

A low price from an unverified compounder isn't a bargain — it's an unpriced risk. Compounded drugs are not FDA-approved, and a particular prescription must meet the applicable compounding requirements3. A license or certification alone does not establish that it qualifies; see the current GLP-1 compounding rules. Favor programs that name a LegitScript-certified pharmacy, and treat prices that look too good to be true as something to confirm, not assume. Our guide on how to vet a cheap compounded GLP-1 walks through the 503A/503B distinction.

Compounded or brand — decide on cost, not habit

If you have insurance that covers Wegovy or Zepbound, brand-name may actually be your cheapest path; if you're paying cash, compare current manufacturer offers with the compounded program's full ongoing charge. Run the math both ways in compounded vs brand-name GLP-1: which actually saves you money before you assume one is cheaper — and check whether you actually qualify for a copay coupon in do GLP-1 savings cards actually lower the price?.

Know the teaser trap when you see it

The most common way shoppers overpay is falling for the $99-then-triples pattern. Learn to spot it in how to spot a GLP-1 teaser-rate trap — it's the single skill that saves the most money over a year of treatment.

Where to comparison-shop

Once you know what to score, put programs side by side. Start with our provider reviews and the head-to-head compare tools to see flat prices, states served, and pharmacy verification in one view — with price conditions kept beside the advertised amounts.

This piece sits in our research index alongside every other sourced explainer we publish — the trials, the compounding rules and the pricing mechanics, grouped by the question each one answers.

Frequently asked questions

What is the most common way people overpay for GLP-1?

Anchoring on a discounted first-month teaser rate that steps up sharply after month one. Always compare the ongoing flat price you'll pay in months three through twelve, not the intro sticker.

Is the cheapest GLP-1 program always the best value?

No. The best value is the lowest ongoing price that also covers your state, comes from a verified pharmacy, and lets you cancel freely. A slightly higher flat rate that scores well on all of those usually beats a rock-bottom teaser.

Do I need tirzepatide, or is semaglutide enough?

For many people a low flat-rate semaglutide is sufficient. Tirzepatide has a higher weight-loss ceiling in trials but costs more, so pay the premium only if you want that ceiling.

References

  1. Wilding JPH, Batterham RL, Calanna S, et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/33567185/
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/35658024/
  3. U.S. Food and Drug Administration (2024). Compounding and the FDA: Questions and Answers. FDA.gov. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers

Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.